8.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Anavex Life Sciences Corporation Borsa (AVXL) Ultime notizie
Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
UPCOMING AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Anavex Life Sciences' (AVXL) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit - ACCESS Newswire
Anavex Life Sciences Corporation Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAVXL - ACCESS Newswire
Wainwright maintains $42 target on Anavex Life Sciences stock By Investing.com - Investing.com Nigeria
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Wainwright maintains $42 target on Anavex Life Sciences stock - Investing.com
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Anavex Life Sciences (NASDAQ:AVXL) Posts Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Earnings call transcript: Anavex Life Sciences Q4 2024 sees net loss, stock rises - MSN
Anavex: Looking At Different Statistical Approaches Before EMA Opinion (NASDAQ:AVXL) - Seeking Alpha
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Call Transcript - MSN
Anavex Life Sciences Reports Higher Quarterly Loss Amid R&D Focus - TipRanks
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot - mySA
Anavex Life Sciences Corp. (AVXL) reports earnings - Quartz
Anavex Life Sciences Corp. Reports Earnings Results for the First Quarter Ended December 31, 2024 - Marketscreener.com
ANAVEX LIFE SCIENCES CORP. SEC 10-Q Report - TradingView
Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update - The Manila Times
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot -February 12, 2025 at 07:40 am EST - Marketscreener.com
Anavex: Further Validation Of Blarcamesine With Schizophrenia Data In 2025 (NASDAQ:AVXL) - Seeking Alpha
Analytical Lens: Exploring Anavex Life Sciences Corporation (AVXL)’s Financial Story Through Ratios - The Dwinnex
Anavex Life Sciences Corporation (AVXL) receives a Neutral rating from Cantor Fitzgerald - Knox Daily
Anavex Life Sciences Corporation (AVXL) Stock: Assessing the Risk and Reward - The News Heater
Anavex Life Sciences (AVXL) to Release Quarterly Earnings on Wednesday - MarketBeat
Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025 - The Manila Times
Anavex Life Sciences Corp. Announces Financial Results Conference Call for First Fiscal Quarter 2025 - Nasdaq
Anavex Q1 2025 Earnings: Strategic Growth Updates Coming February 12 - StockTitan
AVXL DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline - ACCESS Newswire
Anavex Life Sciences (AVXL) to Release Earnings on Wednesday - MarketBeat
JPMorgan Chase & Co. Acquires 1,191 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Receives "Buy" Rating from D. Boral Capital - MarketBeat
HC Wainwright Reaffirms Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Jim Cramer on Anavex Life Sciences Corp. (AVXL): ‘It’s A Good Spec’ - Yahoo Finance
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from D. Boral Capital - Defense World
Anavex Life Sciences Secures New Patent For ANAVEX®2-73 - Evrim Ağacı
NASDAQ: AVXL Lawsuit Update: Investors Who Lost Money With Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) Should Contact the Shareholders Foundation - ACCESS Newswire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):